Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Editas Medicine Inc (NASDAQ: EDIT) closed at $2.23 in the last session, up 4.21% from day before closing price of $2.14. In other words, the price has increased by $4.21 from its previous closing price. On the day, 2.46 million shares were traded. EDIT stock price reached its highest trading level at $2.365 during the session, while it also had its lowest trading level at $2.16.
Ratios:
We take a closer look at EDIT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on November 25, 2024, Downgraded its rating to Underperform and sets its target price to $1 from $13 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 03 ’24 when O’Neill Gilmore Neil sold 1,618 shares for $2.08 per share. The transaction valued at 3,361 led to the insider holds 312,106 shares of the business.
Mei Baisong sold 541 shares of EDIT for $1,124 on Dec 03 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 133,354 shares after completing the transaction at $2.08 per share. On Sep 04 ’24, another insider, Mei Baisong, who serves as the EVP, CHIEF MEDICAL OFFICER of the company, sold 518 shares for $3.42 each. As a result, the insider received 1,774 and left with 133,895 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 184082256 and an Enterprise Value of -42517740. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.34 while its Price-to-Book (P/B) ratio in mrq is 1.05. Its current Enterprise Value per Revenue stands at -0.688 whereas that against EBITDA is 0.191.
Stock Price History:
Over the past 52 weeks, EDIT has reached a high of $11.58, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -22.94%, while the 200-Day Moving Average is calculated to be -54.52%.
Shares Statistics:
According to the various share statistics, EDIT traded on average about 2.22M shares per day over the past 3-months and 2668190 shares per day over the past 10 days. A total of 82.54M shares are outstanding, with a floating share count of 81.78M. Insiders hold about 0.93% of the company’s shares, while institutions hold 67.87% stake in the company. Shares short for EDIT as of 1731628800 were 15905551 with a Short Ratio of 7.16, compared to 1728950400 on 18332613. Therefore, it implies a Short% of Shares Outstanding of 15905551 and a Short% of Float of 24.4.
